Niloofar Taheri

Dr. Niloofar Taheri

orcid

Research Focus & Metrics

Academic Career Length

1Year (2026-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
14 May 2026 in Scientific Reports
Verified
Journal Article
Open access
AAAli Alipour
Ali Alipour
RHReza Mosaddeghi Heris
Reza Mosaddeghi Heris
ADAfra Darvishi
Afra Darvishi
SPShahriar Parvaneh
Shahriar Parvaneh
MTMalihe Talebi
Malihe Talebi
ANAmirreza Naseri
Amirreza Naseri
Oxidative stress is recognized as a key pathological mechanism in multiple sclerosis (MS), and fatigue is one of the most prevalent and disabling symptoms. In this cross-sectional study, 85 patients diagnosed with relapsing-remitting MS (RRMS) and Expanded Disability Status Scale (EDSS) < 4.5 were recruited. Fatigue was evaluated by the Comprehensive Fatigue Assessment battery MS (CFAB-MS), which also assesses fatigue-related factors. Venous blood samples were collected to measure levels of glutathione peroxidase (GPX), catalase (CAT), malondialdehyde (MDA), reduced glutathione (GSH), total antioxidant capacity (TAC), and superoxide dismutase (SOD). Most correlations between oxidative stress markers and fatigue measures were not statistically significant. However, MDA levels showed significant positive correlations with Visual Analog Scale (VAS) scores for sleep problems (r:0.23, p-value:0.04); Walking problems VAS (r:0.31, p-value < 0.01); anxiety and worry (r:0.22, p-value < 0.05); and significant negative correlations with mood (r:-0.21, p-value < 0.05) and fatigue management (r:-0.22, p-value:0.04). Additionally, GSH levels were positively correlated with Fatigue VAS (r:0.24, p-value:0.02) and CAT was negatively correlated with stress VAS (r:-0.21, p-value:0.04). After applying the Benjamini-Hochberg correction, none of the correlations remained statistically significant. At an exploratory level, this study suggests that there is a minimal association between oxidative stress, fatigue and its related factors in minimally disabled RRMS patients.

9 May 2026 in Biology
Verified
Journal Article
Open access
PDF file
RHReza Mosaddeghi Heris
Reza Mosaddeghi Heris
NFNasrin . Forghani
Nasrin . Forghani
NDNegin Safari Dehnavi
Negin Safari Dehnavi
MSMaryam Saberivand
Maryam Saberivand
ATAmir Tahavvori
Amir Tahavvori
PMPaolo Martelletti
Paolo Martelletti
Sensory neurons at barrier tissues were once seen as passive detectors of environmental stimuli. However, in the last five years, increasing evidence has challenged this view, redefining these cells as active immune sentinels that directly affect tissue immunity in the skin, lungs, and gastrointestinal tract. Nociceptors and pruriceptors express various immune-sensing receptors, including Toll-like receptors, cytokine receptors, and alarmin sensors, which allow them to directly detect pathogens, allergens, and tissue damage. When activated, sensory neurons quickly release neuropeptides such as calcitonin gene-related peptide (CGRP), substance P, vasoactive intestinal peptide (VIP), and PACAP (pituitary adenylate cyclase-activating polypeptide), which guide immune cell recruitment, activation, and resolution. Reciprocally, immune-derived mediators, including IL-33, IL-31, thymic stromal lymphopoietin (TSLP), IL-4/IL-13, and TNF-α, modulate neuronal excitability and plasticity, forming bidirectional neuroimmune circuits that control inflammation, host defense, pain, and itch. Landmark studies published in 2024–2025, including neuronal control of gut Treg function and the identification of sensory nerve immune niches, have further refined this framework and revealed tissue-specific circuit specialization. This review synthesizes recent insights from molecular, cellular, and systems levels into the sensory neuroimmune axis, emphasizes its protective versus pathogenic roles, and critically evaluates emerging therapeutic strategies and safety concerns, positioning sensory neuroimmunology as a unifying framework for tissue barrier homeostasis and disease.


26 February 2026 in Toxins
Verified
Journal Article
Open access
PDF file
RHReza Mosaddeghi Heris
Reza Mosaddeghi Heris
MPMojtaba Pandeh
Mojtaba Pandeh
LGLeila Ghorbi
Leila Ghorbi
NTNiloofar Taheri
Niloofar Taheri
MZMaedeh Shariat Zadeh
Maedeh Shariat Zadeh
PMPaolo Martelletti
Paolo Martelletti
Peptides from scorpion venom, mainly in species such as Olivierus martensii (formerly Olivierus martensii Karsch, often designated BMK) (BmK) and Tityus serrulatus from the Buthidae family, show real promise as painkillers that skip opioids altogether. They work by hitting specific ion channels and dialing down inflammation. This review gathers information on their molecular setups: disulfide-bridged types and those without, weighing in at 3 to 10 kilodaltons (kDa). Structural features include motifs stabilized by cysteines. In pain signaling, they block voltage-gated sodium channels (NaV) such as NaV1.7 and NaV1.8; take the BmK analgesic–antitumor peptide (BmK-AGAP) for example. Additionally, scorpion venom heat-resistant peptide (SVHRP) reduces microglia activity. Tests on rodents using formalin injections, acetic acid writhing, and chronic constriction injury (CCI) setups reveal pain relief that depends on dose and stacks up to morphine. Pairings like AGAP with lidocaine decrease the effective dose by half. In terms of safety, therapeutic levels have low-toxicity with a median lethal dose (LD50) over 20 mg/kg. Issues crop up with immune responses, unintended targets, and differences in venom batches. Clinical information remains thin, so gaps persist. Engineered versions could change the game for neuropathic pain, inflammatory conditions, and cancer-related discomfort. Standardization plus Phase I studies would help move this forward.

21 September 2026 in Neuroradiology
Verified
Journal Article
Closed access
PDF file
RHReza Mosaddeghi Heris
Reza Mosaddeghi Heris
KBKimia Bagheri
Kimia Bagheri
AAAli Adib
Ali Adib
ATAmir Tahavvori
Amir Tahavvori
HSHadi Sahrai
Hadi Sahrai
HSHouman Sotoudeh
Houman Sotoudeh

24 May 2026 in Brain and Behavior
Verified
Journal Article
Open access
HAHamid Abbasi
Hamid Abbasi
NTNiloofar Taheri
Niloofar Taheri
Ali JafariAli Jafari
Ali Jafari
Background: Functional/dissociative seizures (FDS) resemble epileptic seizures but occur without EEG abnormalities. Affected patients report fatigue and gastrointestinal symptoms, seeking dietary approaches. Yet, nutrition's role in FDS remains poorly understood. Thus, this mixed‐methods study analyzed Reddit comments to explore patients’ dietary perceptions and emotions. Methods: Comments from r/PNESsupport were collected using specific keywords. Only English‐language comments from inception to September 2025 were included. After short and irrelevant comments were removed, the remaining comments were analyzed using sentiment analysis and reflexive thematic analysis. Analyses were performed using RStudio v2025.05.0 and R v4.3.3. Results: Thirty‐one comments from 23 users with FDS (UwFDS) were analyzed. The total sentiment score was mildly positive (0.080 ± 0.116). Five themes with 12 subthemes emerged: (1) UwFDS emphasized stable blood sugar, noting hypoglycemia and meal timing as seizure triggers; (2) Ketogenic, low‐carbohydrate, and elimination diets were reported as helpful yet raised concerns about hydration and nutritional adequacy; (3) UwFDS described cannabidiol oil, amino acid supplements, and avoiding artificial sweeteners as complementary measures; (4) Food sensitivities and gastrointestinal discomfort were linked to symptom exacerbation or relief; (5) Nutrition was framed as supporting quality of life alongside medical and psychological care. Conclusion: The positive sentiment reflects hope and agency rather than metabolic efficacy. Integrating nutritional care within psychologically informed frameworks honors patient experience while preserving FDS's non‐organic nature. Future research should evaluate whether structured nutritional guidance, embedded in psychologically informed care, improves outcomes and explore mechanisms like interoceptive processing and the gut–brain axis.